16
July 2024
Cirata plc
("Cirata" or the
"Company")
Q2 Trading Update and
Outlook
Cirata plc (LSE: CRTA) today
announces a trading update for the quarter ended 30 June
2024. Cirata has separately launched today
a Placing of Ordinary Shares.
Summary
·
Bookings for Q2 2024 of $1.7m, representing 143%
growth sequentially over Q1 FY24 and YoY growth also of
143%.
·
16 contracts signed with 44% of the value of the
contracts coming from 'new & growth' contracts.
· Continued to
strengthen pipeline volume and quality, driven by increasing
customer, partner and sales activity.
·
Marketing activity increased quarter on quarter,
generating healthy inbound leads.
·
Cash position of $9.1m as at 30 June
2024.
·
Further cost efficiency programme commenced,
targeting reduction in annualised costs from c.$23m to c.
$20m[1].
Outlook
With the current pipeline, prospects
in progress (including those delayed from Q2) and six months of the
year remaining, the Board is retaining its FY24 booking
guidance[2] as, with strong execution, it
remains achievable although demanding with expected bookings Q4
weighted. We believe we will continue to see improving levels
of sales activity, both direct and through partners as we trade
through H2 and our Go-To-Market (GTM) continues to
mature.
The Board believes that the current
levels of lead generation and early-stage pipeline support the
medium-term ambition of the Company.
1 Annualized
overhead run rate commencing FY25
2 FY24
Bookings guidance $13-15m
Trading Update
Bookings in Q2 2024 were $1.7m (Q2
2023: $0.7m), with the business mix driven by DevOps software,
accounting for 63% of bookings and Data Integration (DI) software
accounting for 37% of bookings.
In total, 16 new contracts were
signed in the quarter of which 7 were 'new & growth' contracts,
including the second phase to the previously announced deal with
GM, which validates the Company's 'land & expand'
strategy.
Significant renewals secured in the
quarter included Oppo's 3-year, $592,000 maintenance and support
renewal for Cirata's MultiSite Gerrit product[3].
Deal slippage remained a feature of
Q2 performance. Some of the significant potential deals in Q2
slipped, and following consultation with our customers, we have an
expectation that these will now conclude in H2 matching the
customer critical timelines. The team delivered some improvement on
closing smaller deals, which is encouraging, but challenges remain
around the complex nature of larger enterprise sales for data
integration, with complexity from customer and partner procurement
processes. Establishing greater sales cycle predictability,
therefore, remains a key priority for management to enable Cirata
to move beyond its current non-linear growth trajectory. Today, the
sales team is more established which provides greater confidence in
sales cycle management and deal closure predictability.
Business Review
Following a review of the strategy
completed in April 2024, several strategic decisions were validated
with primary data input from customers, partners and market data,
namely:
1. Grow and invest in the two
product lines - Data Integration (potential triple digit annual
growth) & Dev Ops (potential double digit annual growth).
Functionally, there is a separation between DI and Dev Ops sales
& Product/Engineering teams to execute for growth;
2. Establish two Data
Integration sales geographies (Americas & International) and a
dedicated global Dev Ops focus; and
3. Continue the tactical 8-12 quarters growth plans whilst
developing long-term strategic growth plans in growth markets based
on our core competencies of DI/Dev Ops towards Hybrid Cloud &
AI.
At the appropriate time, the Company
will host a Capital Markets Day to expand on this strategic
intent.
3 Renewal
amount for the whole of the 3-year term
During the past six months, the
Marketing function has 'test driven' various elements of the
marketing mix and there is growing evidence that digital marketing
and account-based marketing efforts are starting to deliver
meaningful inbound leads. The Marketing team is now doubling-down
on certain activities that are yielding improved lead generation
metrics such as a 200% increase in Q2 over Q1 LinkedIn add
performance and an 80% increase in organic search
traffic.
The new GTM organisation is bedding
down and leads from partners and customer activity levels are
increasing and contributing to pipeline growth.
Whilst the first two quarters have
been slower than expected or desired, the January 1 reconfiguration
of the GTM approach accompanied by greater clarity around Cirata's
product offerings have served to improve momentum, which is
encouraging. The pipeline is higher quality, better qualified and
more robust compared to this point last year or indeed 6 months
ago.
Stephen Kelly, Chief Executive Officer,
commented:
"Overall, we are making good progress although I feel this is
not represented in the headline numbers and
I felt we could have reached further in Q2 if it
wasn't for some material deal slippage which we expect to complete
in Q4. Nevertheless, the team did deliver improved sales
conversions and certain deals initially slated for Q2 close are now
slated for H2 close, are aligned to customer timelines and
consistent with our reconfirmed FY24 bookings guidance.
As
part of our ongoing efficiency and effectiveness drive, we have
started a fresh cost alignment program to further reduce annualised
costs from $23m to circa $20m by the end of December 2024. This
compares to the overall annualised cost base of $45m at the end of
March FY23. Our goal is to deliver sustainable high growth with a
fraction of the previous cost base as we improve GTM productivity
and market alignment across the Company.
As
I have said before, the recovery of Cirata is likely to be
non-linear but those who know me understand that I am very
ambitious when it comes to the growth aspirations I have for
companies I lead. With 6 to12 month sales cycles and the need to
re-build the pipeline from its embryonic form when the new
management team arrived, sustainable bookings growth is taking
longer than I had hoped. We can, however, foresee
some major contracts in Q4 FY24 in the pipeline which bodes well
for a strong end of FY24 performance consistent with our retained
guidance. I want to thank our colleagues who show great commitment
to Cirata as well as our customers and investors for their
support."
This announcement contains information that qualifies or may
qualify as inside information for the purposes of Article 7 of the
Market Abuse Regulation (EU) 596/2014 as it forms part of UK
domestic law by virtue of the European Union (Withdrawal) Act 2018
("MAR"), and is disclosed in accordance with the company's
obligations under Article 17 of MAR.
The
person responsible for arranging the release of this announcement
on behalf of Cirata plc is Larry Webster, Company
Secretary.
For
further information, please contact:
Cirata
|
Via
FTI Consulting
|
Stephen Kelly, Chief Executive
Officer
|
|
Ijoma Maluza, Chief Financial
Officer
|
|
Daniel Hayes, Investor
Relations
|
|
|
|
FTI
Consulting
|
+44
(0)20 3727 1137
|
Matt Dixon / Kwaku Aning / Usama
Ali
|
|
|
|
Stifel (Nomad and Joint
Broker)
|
+44
(0)20 7710 7600
|
Fred Walsh / Ben Good / Sarah
Wong
|
|
|
|
Liberum (Joint
Broker)
|
+44
(0)20 3100 2000
|
Max Jones / Rupert Dearden / John
More
|
|
About Cirata
Cirata, accelerates data-driven
revenue growth by automating data transfer and integration to
modern cloud analytics and AI platforms without downtime or
disruption. With Cirata, data leaders can leverage the power of AI
and analytics across their entire enterprise data estate to freely
choose analytics technologies, avoid vendor, platform, or cloud
lock-in while making AI and analytics faster, cheaper, and more
flexible. Cirata's portfolio of products and technology solutions
make strategic adoption of modern data analytics efficient and
automated.
For more information
about Cirata, visit www.cirata.com